⏳ Fetching live dividend data...
Home › Calculator › CKPT Dividend Calculator 2026
Checkpoint Therapeutics, Inc. · NASDAQ
Price: $4.26 · Annual div: $2.00/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in CKPT → $944817302.10M in 10 years · $78,571,340,647,673.58/month
Checkpoint Therapeutics, Inc. is a clinical-stage company specializing in immunotherapy and targeted oncology. Its mission involves discovering, advancing, and bringing to market innovative therapeutic solutions for individuals battling solid tumor cancers. The company's pipeline features several key candidates, including Cosibelimab, a leading fully-human IgG1 monoclonal antibody. This therapy is designed to directly bind to programmed death ligand-1 (PD-L1), thereby inhibiting its interaction with programmed death receptor-1 and B7.1 receptors. Another significant antibody in development is CK-302, a human agonistic antibody intended to bind and activate signaling within GITR-expressing cells. Beyond antibodies, Checkpoint Therapeutics is advancing Olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor specifically for patients with EGFR mutation-positive non-small cell lung cancer. Its portfolio also includes CK-103, a highly selective and potent small molecule designed to inhibit bromodomain and extra-terminal (BET) bromodomains. Furthermore, a fully human, preclinical anti-carbonic anhydrase IX (CAIX) antibody is being developed, which aims to identify and destroy CAIX-expressing cells through both antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC). To broaden its reach, Checkpoint Therapeutics has established collaboration agreements with TG Therapeutics, Inc. These partnerships focus on the joint development and commercialization of specific assets related to its licenses in the area of hematological malignancies. Established in 2014, Checkpoint Therapeutics is headquartered in Waltham, Massachusetts, and operates as a subsidiary of Fortress Biotech, Inc.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CKPT position with:
Real after-tax yield depends on where you live and how you hold CKPT.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 46.95% | 44.15% | $4,695 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 39.91% | 37.11% | $3,991 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 37.56% | 34.76% | $3,756 / yr |
| 🇬🇧 UK ISA | 0% | 46.95% | 44.15% | $4,695 / yr |
| 🇬🇧 UK Taxable | 8.75% | 42.84% | 40.04% | $4,284 / yr |
| 🇨🇦 TFSA | 0% | 46.95% | 44.15% | $4,695 / yr |
| 🇨🇦 CA Taxable | 25% | 35.21% | 32.41% | $3,521 / yr |
| 🇦🇺 Super (pension) | 15% | 39.91% | 37.11% | $3,991 / yr |
| 🇦🇺 AU Taxable | 30% | 32.87% | 30.07% | $3,287 / yr |
| 🇩🇪 DE Taxable | 26.375% | 34.57% | 31.77% | $3,457 / yr |
| 🇫🇷 FR Taxable | 30% | 32.87% | 30.07% | $3,287 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
CKPT pays quarterly — 4 times per year. Next ex-div: TBD.
How CKPT compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CKPT sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| Sale | 2025-05-29 | 100,000 | $1.29 | $129.0K | ||
| D-Return | 2025-05-30 | 6,122,249 | $4.10 | $25.10M | ||
| D-Return | 2025-05-30 | 700,000 | $4.10 | $2.87M | ||
| A-Award | 2025-05-29 | 50,000 | $1.29 | $64.5K | ||
| A-Award | 2025-05-28 | 12,195 | — | — | ||
| U-Tender | 2025-05-30 | 187,007 | $4.10 | $766.7K | ||
| A-Award | 2025-05-28 | 12,195 | — | — | ||
| U-Tender | 2025-05-30 | 147,007 | $4.10 | $602.7K | ||
| A-Award | 2025-05-29 | 50,000 | $1.29 | $64.5K | ||
| A-Award | 2025-05-28 | 12,195 | — | — |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Analyst consensus price target via FMP. Not a guarantee of future performance. Past analyst accuracy varies.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CKPT dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Checkpoint Therapeutics, Inc. (CKPT) is currently trading at $4.26, 89% below its 52-week high. The current dividend yield is 46.95% based on an annual payout of $2.00 per share.
Checkpoint Therapeutics, Inc. (CKPT) is a healthcare stock currently trading at $4.26 with a dividend yield of 46.95%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →